Compared with conventional subtyping markers (e.g., TdT, PRSS16, and PSMB11), CNOT2/9 and SHMT1 not only exhibited good segregating capabilities for thymoma and TSCC, but also showed great prognosis indicating potentials. This evidence concerns the gene CNOT2 and thymoma.